VFA
LABU icon

Valeo Financial Advisors’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Valeo Financial Advisors’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-53
Closed -$61K – 1856
2019
Q4 		$61K Hold
53
– – 0.01% 575
2019
Q3 		$33K Hold
53
– – ﹤0.01% 717
2019
Q2 		$53K Buy
53
+48
+960% +$46.5K 0.01% 578
2019
Q1 		$6K Buy
+5
New +$5.2K ﹤0.01% 1102
2018
Q4 		– Sell
-3
Closed -$3K – 1613
2018
Q3 		$3K Buy
+3
New +$5.89K ﹤0.01% 1355

Other funds holding LABU

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HJMC
Hellman Jordan Management Company Quincy, Massachusetts $58.9M AUM 18.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HIS
Harvest Investment Services Oakbrook Terrace, Illinois $547M AUM 64.58% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Valeo Financial Advisors's LABU Position: Q1 2020 in Review

Valeo Financial Advisors sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2020, closing a stake of 53 shares — an estimated $61K sold.

Valeo Financial Advisors first reported a position in LABU in Q3 2018 and held it in 5 quarters. The position peaked at $61K in Q4 2019. 19 funds tracked by Wall St. Rank hold LABU as of Q1 2020.

  • Valeo Financial Advisors reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2020 after selling out during the quarter.
  • Valeo Financial Advisors sold 53 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2020, an estimated $61K.
  • Valeo Financial Advisors first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2018 and held it in 5 quarters.
  • Valeo Financial Advisors's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $61K in Q4 2019.
  • 19 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2020.

Based on Valeo Financial Advisors's 13F filing for Q1 2020, filed 13 Apr 2020.